QIR Suite vs InVision Precision Cardiac Amyloid

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

QIR Suite

by CASIS Cardiac Simulation & Imaging Software

InVision Precision Cardiac Amyloid

by InVision Medical Technology

AI Verdict

These tools are adjacent, both leveraging AI for cardiovascular imaging analysis but differing significantly in their approach. QIR Suite offers broad quantitative analysis for MR and CT images across various cardiovascular conditions, while InVision Precision Cardiac Amyloid specializes in detecting cardiac amyloidosis specifically from echocardiography studies.

Choose QIR Suite if…

Choose QIR Suite if your clinical practice requires comprehensive, quantitative analysis of a broad spectrum of cardiovascular conditions using advanced imaging modalities like MR and CT. This tool is ideal for detailed evaluation of over 100 clinical parameters, including blood flow, pathological volumes, and strain, to support both diagnosis and prognosis across various cardiac pathologies.

View QIR Suite →

Choose InVision Precision Cardiac Amyloid if…

Choose InVision Precision Cardiac Amyloid if your primary need is the early and accurate detection of cardiac amyloidosis in patients, especially those presenting with heart failure symptoms. This AI-powered software specializes in analyzing transthoracic echocardiogram studies to reduce misdiagnosis and improve outcomes for both AL and ATTR cardiac amyloidosis.

View InVision Precision Cardiac Amyloid →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	QIR Suite	InVision Precision Cardiac Amyloid
Pricing	Contact for pricing	Unknown
Deployment	Locally on dedicated hardware	Cloud or on-premise
BAA Available	Unknown	Yes AI-estimated
FDA Status	Cleared AI-estimated	Cleared AI-estimated
HIPAA	Unknown	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

InVision Precision Cardiac Amyloid

Tool B is deployed as Software as a Medical Device (SaMD) and is explicitly designed for integration into existing clinical workflows for echocardiography labs, suggesting a more seamless user experience. Tool A's local deployment on dedicated hardware may introduce more complexity in setup and ongoing management, despite claims of optimized ergonomics.

Clinical Value

InVision Precision Cardiac Amyloid

While Tool A offers broad analysis across MR and CT with numerous parameters, Tool B provides a highly focused solution for detecting cardiac amyloidosis, a life-threatening and often underdiagnosed disease. Its clinical value is strongly supported by an evidence-based AI algorithm that is peer-reviewed and published in JAMA Cardiology, indicating robust validation for its specific application.

Pricing & Value

InVision Precision Cardiac Amyloid

Tool B offers transparent starting pricing at $49/month, allowing potential customers to more easily assess its value proposition. Tool A requires direct contact for pricing, which can be a barrier to initial evaluation and comparison.

Enterprise Readiness

InVision Precision Cardiac Amyloid

Tool B explicitly states HIPAA compliance and is designed as SaMD for integration into clinical workflows, which are critical for enterprise adoption. Furthermore, it has an established CPT Category III code for reimbursement, addressing a key financial aspect for healthcare enterprises.

Innovation

QIR Suite

Tool A demonstrates a broader scope of innovation by applying AI to both MR and CT imaging for a wide range of cardiovascular conditions, quantifying over 100 clinical parameters. It also claims to be the world's first solution to automatically evaluate myocardial infarction, suggesting a more extensive and diverse innovative platform.

Support & Docs

Tie

Neither the provided structured facts nor the web search results offer sufficient specific, comparable information regarding the quality, availability, or scope of support and documentation for either tool. Therefore, it is not possible to distinguish between them on this dimension.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	QIR Suite	InVision Precision Cardiac Amyloid
Tool Name	QIR Suite	InVision Precision Cardiac Amyloid
Company	CASIS Cardiac Simulation & Imaging Software	InVision Medical Technology Corporation
Primary Imaging Modality	MR and CT images	Echocardiography (transthoracic echocardiogram studies)
Specific Clinical Focus/Detection	Cardiovascular conditions, detection of heart regions and pathological areas	Cardiac amyloidosis (AL and ATTR), earlier detection, reduction of misdiagnosis
Key Quantification/Analysis Capabilities	Quantification of over 100 clinical parameters, automatic segmentation, blood flow/velocities quantification, pathological volumes detection and quantification, semi-quantification of myocardial perfusion, strain quantification	AI-powered detection of cardiac amyloidosis, evaluation of transthoracic echocardiogram studies, precise assessment of wall thickness
Categories	Cardiology AI, Radiology & Imaging AI	Cardiology AI

Videos

Demos, reviews, and walkthroughs featuring QIR Suite and InVision Precision Cardiac Amyloid.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What specific cardiovascular conditions do these tools help diagnose or assess?

QIR Suite is designed for the quantitative evaluation of various cardiovascular conditions using MR and CT images, supporting both diagnosis and prognosis. InVision Precision Cardiac Amyloid, on the other hand, is specifically an AI-powered software for the detection of cardiac amyloidosis from echocardiography studies, aiming for earlier diagnosis and improved patient outcomes.

What imaging modalities are supported by each software?

QIR Suite performs AI-based analysis of MR and CT examinations. InVision Precision Cardiac Amyloid evaluates transthoracic echocardiogram studies, specifically apical-4-chamber and parasternal-long-axis view videos.

What are the key differences in the analytical capabilities and parameters provided by each tool?

QIR Suite quantifies over 100 clinical parameters, including automatic segmentation, blood flow/velocities, pathological volumes, semi-quantification of myocardial perfusion, and strain quantification. InVision Precision Cardiac Amyloid focuses on AI-powered detection of cardiac amyloidosis, precise assessment of wall thickness in the parasternal long axis view, and supports both AL and ATTR Cardiac Amyloidosis.